139 related articles for article (PubMed ID: 36675604)
1. Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study.
Luo S; Wu L; Li M; Wang J; Wang C; Yang J; Zhang L; Ge J; Sun C; Li E; Lei J; Zhou F; Liao W
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675604
[TBL] [Abstract][Full Text] [Related]
2. Validation of a supplementary condition of eighth AJCC staging system for stage II hepatocellular carcinoma.
Li M; Wu L; Luo S; Liu Y; Sun C; Li E; Wang J; Li B; Huang Z; Ge J; Lei J; Zhou F; Liao W
Eur J Surg Oncol; 2023 Jul; 49(7):1217-1225. PubMed ID: 36690533
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
Kamarajah SK
J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
[TBL] [Abstract][Full Text] [Related]
4. Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.
Lamarca A; Santos-Laso A; Utpatel K; La Casta A; Stock S; Forner A; Adeva J; Folseraas T; Fabris L; Macias RIR; Krawczyk M; Krawczyk M; Cardinale V; Braconi C; Alvaro D; Evert M; Banales JM; Valle JW;
Hepatology; 2021 Jun; 73(6):2311-2325. PubMed ID: 33073396
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
6. Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study.
Levy NA; Kern G; Shepshelovich D; Shibolet O; Hershkoviz R; Isakov O
Oncotarget; 2020 Nov; 11(47):4438-4447. PubMed ID: 33315979
[TBL] [Abstract][Full Text] [Related]
7. Nomograms predict survival outcome of Klatskin tumors patients.
Qi F; Zhou B; Xia J
PeerJ; 2020; 8():e8570. PubMed ID: 32110489
[TBL] [Abstract][Full Text] [Related]
8. Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study.
Yin L; Zhao S; Zhu H; Ji G; Zhang X
Sci Rep; 2021 Jun; 11(1):12166. PubMed ID: 34108604
[TBL] [Abstract][Full Text] [Related]
9. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
Liao P; Cao L; Chen H; Pang SZ
Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Preoperative Inflammation-Based Prognostic Scores in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study.
He C; Zhao C; Lu J; Huang X; Chen C; Lin X
Front Oncol; 2021; 11():672607. PubMed ID: 34221991
[TBL] [Abstract][Full Text] [Related]
12. The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis.
Moustafa M; Fasolo E; Bassi D; D'amico FE; Gringeri E; Pawlik TM; Cillo U
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):632-637. PubMed ID: 31812289
[TBL] [Abstract][Full Text] [Related]
13. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
[TBL] [Abstract][Full Text] [Related]
14. Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study.
Xing H; Tan B; Yang C; Zhang M
Front Med (Lausanne); 2022; 9():846276. PubMed ID: 35433765
[TBL] [Abstract][Full Text] [Related]
15. Sublobar Resection Versus Lobectomy for Early-Stage Pulmonary Carcinoid Tumors ≤3 cm in Size: A SEER Population-Based Study.
Xu S; Li X; Ren F; He J; Zhao S; Wang Y; Ren D; Zhu S; Lei X; Chen G; Chen J
Ann Surg; 2022 Dec; 276(6):e991-e999. PubMed ID: 33196487
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study.
Yang Z; Shi G
Cancer Med; 2022 Feb; 11(3):692-704. PubMed ID: 34862762
[TBL] [Abstract][Full Text] [Related]
18. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
[TBL] [Abstract][Full Text] [Related]
19. Effect of Tumor Size on Long-Term Survival After Resection for Solitary Intrahepatic Cholangiocarcinoma.
Kong J; Cao Y; Chai J; Liu X; Lin C; Wang J; Liu J
Front Oncol; 2020; 10():559911. PubMed ID: 33552949
[TBL] [Abstract][Full Text] [Related]
20. Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis.
Xie D; Qian B; Yang J; Peng X; Li Y; Hu T; Lu S; Chen X; Han Y
Front Oncol; 2020; 10():598048. PubMed ID: 33194764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
